EvroSure
Expel Restenosis Rate
Cobalt Chromium Everolimus
Eluting Coronary Stent
The Everolimus Drug-Eluting Cobalt Chromium Coronary Stent System is designed to improve the diameter of coronary arteries in patients with symptomatic ischemic heart disease. It is suitable for treating de novo lesions in native coronary arteries with a reference vessel diameter ranging from 2.25 mm to 4.5 mm and a lesion length between 8 mm and 54 mm. This stent is intended for use in patients who are eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA).
The EvroSure contains Everolimus at a dose of 1.1 µg/mm² provides optimum anti-proliferation and endothelial regeneration, which in-turn assist to reduce Restenosiss.
For Unbeatable deliverbility which achieves:
Finely engineered elements of an expansive Cobalt Chromium L605 platform, enhances stent flexibility.
Characteristics
Stent Material: Surgical Grade Cobalt chromium (L605), laser cut from
seamless tubing in a serpentine pattern coated with a
polymer and Everolimus mixture.
Delivery system
usable length: 142 CM
Delivery System Y-Adaptor
Ports: Single access port to the inflation/deflation lumen.
A guidewire exit port is located at 25cm from the tip.
Designed for guidewire 0.014″ (0.36mm).
Balloon inflation pressure: Nominal inflation pressure: 9 atm ,Rated burst pressure: 16 atm
Guiding catheter inner
diameter: 5 Fr(1.4mm) Compatible Guide Wire 0.014 inch
Strut Thickness (µm): 59
Polymer Bio-Degradation: 100% 6-7 Weeks
Stent Recoil: <6%
Foreshortening: <2%
Stent architecture: Hybrid Cell Design with Non-Linear links
Reviews here are order-verified. Only buyers who completed a delivered order can rate this supplier, so the first review appears after the first delivery on BharatSeal.
Questions & answers
Ask the supplier. Answers are visible to all buyers
No questions yet. Ask the first one: the supplier is notified and the answer is posted here for every buyer.